Renal and vascular effects of C-type and atrial natriuretic peptides in humans

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 273, Issue 4 42-4, 1997, Pages

  Pham, Isabelle ^a   Sediame, Saïd ^a   Maistre, Geneviève ^b   Roudot Thoraval, Françoise ^a   Chabrier, Pierre Etienne ^c   Carayon, Alain ^b   Adnot, Serge ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Institut Henri Beaufour   (France)

Author keywords

Renal function; Vascular tone

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ALPHA; NATRIURETIC PEPTIDE TYPE C; RENIN;

ADULT; ARTICLE; BLOOD VESSEL TONE; BLOOD VOLUME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURESIS; DOSE RESPONSE; GLOMERULUS FILTRATION; HUMAN; HUMAN EXPERIMENT; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MALE; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0030716894     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1997.273.4.r1457     Document Type: Article

References (18)

1. Adnot, S., P. Andrivet, P. E. Chabrier, J. Piquet, P. Plas, P. Braquet, F. Roudot-Thoraval, and C. Brun-Buisson. A trial natriuretic factor in chronic obstructive lung disease with pulmonary hypertension. J. Clin. Invest. 83:986-993, 1989.
2. Bie, P., B. C. Wang, R. J. Leadley, Jr., and K. L. Goetz. Hemodynamic and renal effects of low-dose infusions of atrial peptide in awake dogs. Am. J. Physiol. 254 (Regulatory Integrative Comp. Physiol. 23):R161-R169, 1988.
3. Biollaz, J., J. Nussberger, M. Porchet, F. Brunner-Ferber, E. S. Otterbein, H. Gomez, B. Waeber, and H. R. Brunner. Four-hour infusions of synthetic atrial natriuretic peptide in normal volunteers. Hypertension 8, Suppl. II:II-96-II-105, 1986.
4. Brandt, R. R., D. M. Heublein, L. L. Aarhus, J. A. Lewicki, and J. C. Burnett, Jr. Role of natriuretic peptide clearance receptor in in vivo control of C-type natriuretic peptide. Am. J. Physiol. 269 (Heart Circ. Physiol. 38):H326-H331, 1995.
5. Brown, J., and Z. Zuo. Renal receptors for atrial and C-type natriuretic peptides in the rat. Am. J. Physiol. 263 (Renal Fluid Electrolyte Physiol. 32):F89-F96, 1992.
6. Canaan-Kühl, S., R. L. Jamison, B. D. Myers, and R. E. Pratt. Identification of "B" receptor for natriuretic peptide in human kidney. Endocrinology 130:550-552, 1992.
7. Cargill, R. I., A. D. Struthers, and B. J. Lipworth. Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II. Cardiovasc. Res. 29:108-111, 1995.
8. Charles, C. J., E. A. Espiner, M. A. Richards, M. G. Nicholls, and T. G. Yandle. Biological actions and pharmacokinetics of C-type natriuretic peptide in conscious sheep. Am. J. Physiol. 268 (Regulatory Integrative Comp. Physiol. 37):R201-R207, 1995.
9. Clavell, A. L., A. J. Stingo, C.-M. Wei, D. M. Heublein, and J. C. Burnett, Jr. C-type natriuretic peptide: a selective cardiovascular peptide. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33):R290-R295, 1993.
10. Cody, R. J., S. A. Atlas, J. H. Laragh, S. H. Kubo, A. B. Covit, K. S. Ryman, A. Shaknovich, K. Pondolfino, M. Clark, M. J. F. Camargo, R. M. Scarborough, and J. A. Lewicki. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J. Clin. Invest. 78:1362-1374, 1986.
11. Cozza, E., M. Foecking, M. Vila, and C. Gomez-Sanchez. Adrenal receptors for natriuretic peptides and inhibition of aldosterone secretion in calf zona glomerulosa. Acta Endocrinol. 129:59-64, 1993.
12. Dean, A. D., M. Vehaskari, and J. E. Greenwald. Synthesis and localization of C-type natriuretic peptide mammalian kidney. Am. J. Physiol. 266 (Renal Fluid Electrolyte Physiol. 35):F491-F496, 1994.
13. Dunn, B. R., I. Ichikawa, J. M. Pfeffer, J. L. Troy, and B. M. Brenner. Renal and systemic hemodynamic effects of synthetic atrial natriuretic peptide in the anesthetized rat. Circ. Res. 59:237-246, 1986.
14. Ebert, T. J., M. M. Skelton, and A. W. Cowley, Jr. Dynamic cardiovascular responses to infusions of atrial natriuretic factor in humans. Hypertension 11:537-544, 1988.
15. Granger, J. P., T. J. Opgenorth, J. Salazar, J. C. Romero, and J. C. Burnett. Long-term hypotensive and renal effects of atrial natriuretic peptide. Hypertension 8, Suppl. II: II-112-II-116, 1986.
16. Hunt, P. J., A. M. Richards, E. A. Espiner, M. G. Nicholls, and T. G. Yandle. Bioactivity and metabolism of C-type natriuretic peptide in normal man. J. Clin. Endocrinol. Metab. 78:1428-1435, 1994.
17. Igaki, T., H. Itoh, S.-I. Suga, Y. Ogawa, N. Hama, Y. Komatsu, I. Tanaka, T. Yoshimasa, and K. Nakao. Biological actions of intravenously administered C-type natriuretic peptide, a novel endothelium-derived relaxing peptide in humans (Abstract). Circulation 90:I-72, 1994.
18. Kenny, A. J., A. Bourne, and J. Ingram. Hydrolysis of human and pig natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. Biochem. J. 291:83-88, 1993.